Clover begins trials of COVID-19 vaccine with Dynavax and GSK adjuvants
The Chinese company Clover Biopharmaceuticals revealed the start of a randomized, double-blind, human stage Phase I placebo-controlled clinical study to
Read moreThe Chinese company Clover Biopharmaceuticals revealed the start of a randomized, double-blind, human stage Phase I placebo-controlled clinical study to
Read moreAlgernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read moreAstraZeneca is going to expedite the development of the University of Oxford investigational COVID-19 vaccine with a $1 billion BARDA
Read moreNubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read moreScientists at clinical-stage biopharmaceutical company Harbour BioMed (HBM), Utrecht University and Erasmus Medical Center announced that they have discovered a
Read moreSwiss pharma giant Roche has received Emergency Use Authorisation (EUA) from the FDA for its latest COVID-19 antibody test –
Read moreThe U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for emergency use of Gilead’s remdesivir
Read moreModerna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read moreUK-headquartered AstraZeneca and Oxford University announced an agreement to develop and distribute the university’s future recombinant adenovirus vaccine to prevent
Read moreJapanese research-driven pharmaceutical company Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. announced on April 28 that the
Read more